Steven D Feinberg, Gerald M Aronoff, James Ausfahl, Daniel Bruns, Beth D Darnall, Robert L Goldberg, Scott Haldeman, James E Lessenger, Steven Mandel, Tom G Mayer, Annu H Navani, Albert J Osbahr, Pamela A Warren, Thomas H Winters, Jeffrey S Harris, Kurt T Hegmann
{"title":"acem指南：大麻。","authors":"Steven D Feinberg, Gerald M Aronoff, James Ausfahl, Daniel Bruns, Beth D Darnall, Robert L Goldberg, Scott Haldeman, James E Lessenger, Steven Mandel, Tom G Mayer, Annu H Navani, Albert J Osbahr, Pamela A Warren, Thomas H Winters, Jeffrey S Harris, Kurt T Hegmann","doi":"10.1097/JOM.0000000000003548","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Cannabis use is expanding rapidly, and a guideline is needed to address workplace issues.</p><p><strong>Methods: </strong>The ACOEM Guidelines methodology was used to develop an evidence-based guideline.</p><p><strong>Results: </strong>There is some evidence suggesting potential efficacy of cannabis for treatment of spasticity associated with multiple sclerosis. There is no quality evidence of efficacy for treatment of common and typical work-related disorders such as back pain, chronic radiculopathy, neuropathic pain, and other acute or chronic pain disorders. There also is no quality evidence for perioperative use. There are many adverse effects, including cancers, cardiovascular diseases, psychotic disorders, and safety risks. There is rising concern cannabis may cause schizophrenia.</p><p><strong>Conclusions: </strong>Cannabis is not recommended for treatment of typical potentially work-related conditions. Cannabis use for any purpose is not recommended for those in safety-sensitive positions.</p>","PeriodicalId":94100,"journal":{"name":"Journal of occupational and environmental medicine","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ACOEM Guidelines: Cannabis.\",\"authors\":\"Steven D Feinberg, Gerald M Aronoff, James Ausfahl, Daniel Bruns, Beth D Darnall, Robert L Goldberg, Scott Haldeman, James E Lessenger, Steven Mandel, Tom G Mayer, Annu H Navani, Albert J Osbahr, Pamela A Warren, Thomas H Winters, Jeffrey S Harris, Kurt T Hegmann\",\"doi\":\"10.1097/JOM.0000000000003548\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Cannabis use is expanding rapidly, and a guideline is needed to address workplace issues.</p><p><strong>Methods: </strong>The ACOEM Guidelines methodology was used to develop an evidence-based guideline.</p><p><strong>Results: </strong>There is some evidence suggesting potential efficacy of cannabis for treatment of spasticity associated with multiple sclerosis. There is no quality evidence of efficacy for treatment of common and typical work-related disorders such as back pain, chronic radiculopathy, neuropathic pain, and other acute or chronic pain disorders. There also is no quality evidence for perioperative use. There are many adverse effects, including cancers, cardiovascular diseases, psychotic disorders, and safety risks. There is rising concern cannabis may cause schizophrenia.</p><p><strong>Conclusions: </strong>Cannabis is not recommended for treatment of typical potentially work-related conditions. Cannabis use for any purpose is not recommended for those in safety-sensitive positions.</p>\",\"PeriodicalId\":94100,\"journal\":{\"name\":\"Journal of occupational and environmental medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of occupational and environmental medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/JOM.0000000000003548\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of occupational and environmental medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/JOM.0000000000003548","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Objective: Cannabis use is expanding rapidly, and a guideline is needed to address workplace issues.
Methods: The ACOEM Guidelines methodology was used to develop an evidence-based guideline.
Results: There is some evidence suggesting potential efficacy of cannabis for treatment of spasticity associated with multiple sclerosis. There is no quality evidence of efficacy for treatment of common and typical work-related disorders such as back pain, chronic radiculopathy, neuropathic pain, and other acute or chronic pain disorders. There also is no quality evidence for perioperative use. There are many adverse effects, including cancers, cardiovascular diseases, psychotic disorders, and safety risks. There is rising concern cannabis may cause schizophrenia.
Conclusions: Cannabis is not recommended for treatment of typical potentially work-related conditions. Cannabis use for any purpose is not recommended for those in safety-sensitive positions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
